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Our study describes characteristics of DS use among middle-aged Norwegian, including 
medication use and socioeconomic factors. 
Material and methods 
This is a cross-sectional analysis of questionnaire data from 3231 women (born 1943-57) from 
the Norwegian Women and Cancer study, data collected in 2003-2006, response rate 72%. 
Results 
The prevalence of DS use (during past week) was 71% (2297 of 3231 women), while 48% used 
dietary supplement and medication concurrently. Omega-3 and vitamin/minerals were the most 
frequent categories. Among users, 60% used more than one supplement and 12 % used four or 
more. Use was associated with higher age, education, income, medication use and markers of a 
healthy lifestyle (physical activity, lower body mass index, non-smoking). Similar associations 
were found for extent of DS use (number of products). The association between medication and 
supplement use was primarily due to high supplement use among women taking medication for 
less serious disorders and for muscle/joint/pain and cardiovascular disease.  
Interpretation 
Dietary supplements were extensively used among middle-aged Norwegian women. Use was 
associated with socioeconomic, lifestyle and health-related factors, including medication use 




Dietary supplement user patterns among Norwegian middle-aged 
women 
Background 
Use of dietary supplements (DS) in Norway increased extensively from 1986 to 2004 [1]. Total 
sales have not changed noteworthy thereafter, but there has been some increase in sales of 
omega-3 and a slight decrease in the category «other supplements» (including herbs) after 2006 
[2].  
Reports from other countries with a so-called western lifestyle suggest that women use more DS 
than men, and most show that prevalence of use increases with increasing age, socioeconomic 
status and healthy lifestyle [3-7]. However, some inconsistencies exists, either due to true 
geographical variation or caused by varying definitions of DS use. 
Research on DS use in Norway is sporadic [8], but there are publications on use of herbs among 
pregnant women [9], and among patients [10-13]. Data from the Norwegian Women and Cancer 
study (NOWAC) have shown that use of cod-liver oil among Norwegian women is associated 
with variables indicating a healthy lifestyle [14]. A large European cohort study showed a wide 
variation in supplement use across Europe (use the previous 24 hours) [15]. The prevalence 
varied from 2% (Greek men) to over 60% (Norwegian women).  
Health personnel usually regard DS as a positive initiative if the user has some medical need, 
such as vitamin deficiency. Many are worried, however, for the potential health risk associated 
with unnecessary use, particularly among persons who combine use of medication and DS [11, 
12, 16, 17]. Studies investigating use of complementary and alternative medicine (CAM) in 
general, or DS in particular, have shown that patients take a substantial amount of DS [11-13, 
18-20]; not necessarily for treatment of disease, but rather for strengthening their general 
health [20]. It has also been shown that most users do not discuss their DS use with health 
personnel, mostly because they are not asked about it [11]. 
The aim of this study was to describe the pattern of DS use among middle-aged Norwegian 




Material and methods 
The Norwegian Women and Cancer study (NOWAC) is a nationwide, population based cohort 
study with participants randomly sampled from the Central Population Register, held by 
Statistics Norway [21]. Since 1991, approximately 170 000 women have answered 
questionnaires on health, lifestyle and demography. 
From 2002 to 2006 approximately 50 000 women participated in the blood sample collection for 
the NOWAC biobank (response rate 71%). Participants (born 1943-1957) gave detailed 
information on their use of medication and DS during the week preceding the blood draw. 
The women were invited in groups of 500 for practicality. Data from nine randomly chosen 
groups (4500 invited) were electronically available at the time of analysis and comprise the basis 
of our study sample of 3231 women (response rate 72%). 
Variables 
The questions on DS use were “Have you taken X during the past week?”, where X denotes the 
following four DS types: cod-liver oil (liquid), capsules containing fish oil/omega-3, soy and other 
DS (vitamin/minerals). Use of DS was defined as answering yes to one or more of these four 
questions. The participants were asked to list the brand names of all products used in each 
category, except cod-liver oil. The supplements were further categorized according to main 
content as omega-3 (including cod-liver oil and vitamin/mineral combinations), vitamin/minerals 
(except combinations with omega-3), other polyunsaturated fatty acids (PUFAs), herbs/herbal 
extracts/mixtures, soy, and others (including unknown). 
The questions on medication use were “Have you taken X during the past week?”, where X 
denotes the following three categories: oral contraceptives (OC), menopausal hormone therapy 
(MHT) and other medication. Use of medication was defined as answering yes to one or more of 
these three questions. Participants were asked to list all medications used. Medications were 
coded according to the Anatomic Therapeutic Chemical (ATC) classification system [22]. The ATC 
codes were further classified into the following 12 categories: infection (cold/flu medication and 
antibiotics), allergy, gynecological (excluding OC), cancer/immune system/opioids(strong) 
(including systemic corticosteroids), muscle/joint/pain, asthma/Chronic Obstructive Pulmonary 
Disease (COPD), cardiovascular disease (CVD), psychiatry (including epilepsy and Parkinson’s), 
5 
 
hypothyroidism, diabetes, OC, and other (gastrointestinal, prescription vitamins/minerals, 
glaucoma, anemia, and dermatological medication among others). 
Self-perceived health was categorized as very good, good or poor (response alternatives poor 
and very poor were combined due to small numbers). Marital status was dichotomized into 
living alone (unmarried, divorced, widow) or in a relationship (married, cohabitant). 
Employment was categorized as full-time work, part-time work or unemployed (student, 
housewife, pensioner (age- or disability-)). Smokers were defined as women who answered yes 
to the question “have you been smoking during the past week?” Age, years of education, body 
mass index (BMI, kg/m2) and physical activity (discrete scale 1-10) were included in the analyses 
as continuous variables. 
Statistics 
Statistical analyses were performed using IBM SPSS Statistics version 21. Potential associations 
between DS use and sociodemographic and -economic characteristics were analyzed using 
Pearson’s Chi-squared test for categorical variables and Student’s t-test for continuous 
variables. Analyses adjusted for covariates were performed using multiple logistic regression. 
Analysis of variance (ANOVA) was used to analyze the potential association between the extent 
of DS use (number of products) and continuous variables (age, education, BMI and physical 
activity). P-values below 5% were considered statistically significant. 
Ethics 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki. 
NOWAC is approved by the Regional Committee for Medical and Health Research Ethics in North 
Norway. Storage of data is in compliance with the rules of the Norwegian Data Inspectorate. 
Written informed consent was obtained from all participants. 
Results 
There were extensive DS use among the study population. Among the 3231 women, 2297 (71%) 
used DS, while 1549 (48%) were taking DS and medication concurrently. Among the DS users, 
1383 (60%) used more than one supplement and 277 (12%) used four or more. Omega-3 was 
the most used DS (78% of 2297 DS users), followed by vitamin/mineral supplements (49%) and 
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herbal products (22%) (Figure 1). Omega-3 was used as a single supplement much more 
frequently than other supplement categories. The relative proportion of herb users increased 
with increasing number of products (data not shown). 
Use of DS was associated with several demographic and health related factors. The unadjusted 
analyses showed an association between use of DS and the variables age, education, household 
income, medication use (dichotomous), BMI, physical activity and smoking (Table 1). These 
associations remained significant after adjustment. The odds for being a DS user was higher with 
higher age, education and physical activity, and lower with increasing BMI. Medication users had 
higher odds for being DS users than those who did not take medication, and smokers had 30% 
lower odds for being DS users than non-smokers. 
As soy supplements are mainly used for menopausal symptoms, we assessed a potential 
association with menopausal status and MHT. We found strong significant relationships 
between soy supplementation and both menopausal status and MHT use (Table 2). Women 
having irregular or no menstruation periods were three times more likely to use soy 
supplements. Women using MHT were 68% less likely to use soy.  
When classifying supplement users according to number of products used, we found an 
association between higher number of products and higher age, higher education, higher 
physical activity and lower BMI (Figure 2). There were also fewer smokers and more medication 
users with increasing number of DS products used (p<0.05, data not shown). 
Through the categorization of medication users, we could further investigate the variation in DS 
use according to medication use. The highest prevalence of DS use was found among 
participants using medication for less serious disorders, for instance infection, allergy and 
“other” (figure 3). The latter includes gastrointestinal medication (72%). The three largest 
medication categories: muscle/joint/pain, CVD and gynecological medication (mainly MHT), also 
contributed to the association between medication and DS use. Diabetes and OC were the only 
categories with lower proportion of DS use than among non-medication users.  
Discussion 
This study shows that over 70% of middle-aged Norwegian women use DS, almost 50% 
combines DS use with medication, and over 10% of users report four or more DS products. This 
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is a high prevalence compared with other European countries [15], and at least as high as 
concurrent estimates from the National Health and Nutrition Examination Survey (NHANES, 
United States) [7], especially as NHANES defines prevalence based on use the previous 30 days. 
We find that supplement use is associated with higher age, higher socioeconomic status and 
markers of a healthy lifestyle (non-smoking, physical activity and lower BMI), in line with 
previous publications [3-7]. 
Omega-3 products are popular, with a long Norwegian tradition of cod-liver oil use [14]. Most 
omega-3 products also contain vitamins, either as a natural component in the fish oil or as 
added components. It is therefore not surprising that omega-3 products are the most frequent 
category, particularly among single product users. 
Previous publications have shown extensive DS use among patients [11-13, 18-20]. Thus, the 
identified high prevalence of DS use among medication users was anticipated. Our cross-
sectional cannot inform on causal associations, but it seems that women taking medication for 
less serious disorders are the most frequent DS users, perhaps reflecting that people with 
serious disorders receive effective treatment through conventional health services. Most people 
are aware that DS cannot treat serious disease. Regarding diabetes, less use of DS could be a 
marker of a less healthy lifestyle that may have led to diabetes. A lower proportion of DS use 
among OC users probably reflects the younger age and thereby lower general morbidity than 
the population average. However, these small numbers should be interpreted with caution. 
Users of medication for less serious disorders, and perhaps disorders for which medical 
treatment is less successful, may be more inclined to resort to DS. An Australian survey showed 
that the use of CAM varied greatly between diagnoses [18]. Among women aged 30-59 years, 
the prevalence of CAM use was >40% for women with arthritis and osteoporosis, and <10% for 
women with asthma, diabetes and CVD. Although the numbers are not directly comparable to 
our study, we see that the prevalence is higher among those with chronic but not life-
threatening disease. A previous Norwegian study among patients in general practice also found 
the highest proportion of supplement use among users of medications for gastro-intestinal 
conditions [11]. Contrary to our study, they found that antihistamine users had the lowest 
proportion of supplement use. Such differences could be explained by differences in study 
populations or by their investigation of herbal supplements versus DS in our study. The low 
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number of participants per category in the general practice study also make their estimates 
harder to interpret. 
Almost half of the study population used medication and DS concurrently. This is a matter of 
concern for health personnel since it could imply serious risk for some of the users [12, 17]. 
Herbs are considered the main problem regarding DS–medication interactions. The relatively 
high proportion taking many DS products is therefore noteworthy, as the percentages of both 
herb use and medication use increases with increasing number of DS. Herbs are more likely used 
for specific medical conditions compared to omega-3 and vitamin/minerals, which are primarily 
used to prevent ill health in general. Considering the diversity of herbal products, these user 
groups were too small in this material to be investigated individually regarding user 
characteristics, medication use etc, although this would be interesting in a larger data material. 
The exception is soy, with high prevalence of use and with a clearly defined content and medical 
indication (menopausal symptoms). As expected, we find a strong relationship between soy use 
and menopausal status, as well as an inverse relationship between MHT use and soy use.  
Use of DS increased with increasing education and income. For education, this is in line with 
studies from other countries [3, 4, 6, 7]. Income is less investigated, but sales statistics from the 
Health Food Trade Association suggest that income may influence consumption trends in 
Norway [2]. 
Limitations and strengths 
All data were self-reported. NOWAC has previously documented high correlation between 
reported intake of cod-liver oil/omega-3 supplements and serum fatty acid and vitamin D 
concentrations [23, 24]. MHT use has been validated against plasma hormone concentrations 
[25]. Questions on current use (the past week) will usually ensure accordance with real use, 
particularly regular use [26]. The opportunity to list all products should ensure as complete a 
reporting as possible. However, some underreporting cannot be ruled out. The question on 
other DS specifies “(vitamins/minerals)” which may have caused underreporting of purely herbal 
products, and some products will simply be forgotten.  
Length or frequency of use could not be established from our material. Instead, we applied 
number of DS reported as a measure of extent of DS use.  
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The indication for use was not recorded for neither medication nor DS use, so the distinction 
between medication for serious and less serious disorders will be rather crude. Additionally, 
some participants contributed in more than one medication category. Our interpretation of DS 
use according to seriousness of disease should be interpreted accordingly. 
Our questionnaire measures point prevalence, while many other studies of DS use measure 
period prevalence, for instance one-year prevalence. For investigating concurrent use of DS and 
medication, point prevalence is most relevant. If the aim had been to define total use and to 
provide a better estimate of the distribution of use across different supplement types, a one-
year prevalence would have been preferred. Using point prevalence, the results might to a 
greater extent be influenced by seasonal variation. In our study the questionnaire (9 emissions) 
was distributed at different seasons (3 autumn, 2 spring and 4 winter) so a potential seasonal 
influence should be evened out. 
NOWAC is a large population based cohort with random sampling of participants from the 
Central Population Register and acceptable response rate. The participants are considered 
representative for Norwegian middle-aged women [27]. Data was collected 10-15 years ago, but 
neither sales figures [2] nor the biannual report from NAFKAM (National Research Center in 
Complementary and Alternative Medicine) [28] suggest that the consumption of DS has changed 
dramatically since then. 
We need updated knowledge about use of DS and questions regarding this topic should be 
included in comprehensive, repeated data collections, like the large health surveys and the 
NAFKAM survey. The Norwegian mother and child study (MoBa) [29], probably has the most 
extensive DS database in Norway, and work is being done to make this database available [30]. 
Conclusion 
The majority of middle-aged Norwegian women used dietary supplements and about half 
combined the use of medication and dietary supplements. More than one in ten supplement 
users took four or more products. There was an association between use of dietary supplements 
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Table and figures 
Table 1 Participant characteristics and dietary supplements (DS) use (number(%) or 
mean(SD)) 
    Not using DS DS users P valuea  ORb (95% CI) 
    n = 919a n = 2297 unadjusted     
Age, years,  mean (SD) 54.2 (4.0) 55.1 (4.0) <0.01 1.07 1.04-1.09 
Education, years, mean (SD) 12.6 (3.4) 13.0 (3.4) 0.01 1.03 1.00-1.06 
Household gross income, n (%) 
       
 





300 000 - 600 000 NOK 431 (48.6) 1114 (51.0) 
 
1.31 1.02-1.68  
> 600 000 NOK 227 (25.6) 604 (27.6) 0.03 1.40 1.03-1.91 
Employment, n (%) 
       
 





Part-time work 258 (28.5) 673 (29.7) 
 
1.04 0.85-1.27  
Unemployed 175 (19.3) 419 (18.5) 0.75 1.01 0.77-1.31 
Marital status, n (%) 
       
 
Alone 164 (18.0) 421 (18.5) 
   
 
In relationship 745 (82.0) 1858 (81.5) 0.78 0.82 0.63-1.07 
Self-perceived health, n (%) 
       
 





Good 541 (60.5) 1379 (62.5) 
 
1.20 0.98-1.47  
Bad (including very bad) 71 (7.9) 172 (7.8) 0.58 1.26 0.85-1.86 
Medication use, n (%) 
       
 
No 360 (39.2) 769 (33.5) 
   
 
Yes 559 (60.8) 1528 (66.5) <0.01 1.22 1.02-1.47 
BMI, kg/m2, mean (SD) 26.1 (4.6) 25.5 (4.3) <0.01 0.97 0.95-0.99 
Physical activityc, mean (SD) 5.6 (1.9) 5.8 (1.8) <0.01 1.06 1.01-1.11 
Smoking, n (%) 
       
 
No 630 (69.1) 1747 (76.2) 
   
 
Yes 282 (30.9) 545 (23.8) <0.01 0.70 0.57-0.85          
DS= Dietary supplements, OR= Odds Ratio, CI= Confidence interval, BMI= Body Mass Index (kg/m2) 
a Missing information on DS use for 15 participants 
b Student's t-test (continuous variables) or Chi2 test (categorical variables) 
c Logistic regression, mutually adjusted for the listed covariates 
d Discrete scale from 1 to 10 
Significant results are marked in bold. Number of participants with missing information vary from zero (age) to 208 (physical activity). 





Table 2 Use of soy supplements in relation to menopausal status and use of menopausal 
hormone therapy (number(%)) 
  
Not using soy Soy users P valueb ORc (95 % CI)   
n=2941a n=180 unadjusted 
  
Menstruation, n (%)     
   
 
Regular (premenopausal) 392 (97.3) 11 (2.7)  ref.   
Irregular (perimenopausal) 239 (91.9) 21 (8.1)  3.19 1.51-6.76  
No menstruation (postmenopausal) 2284 (94.2) 147 (6.0) 0.01 3.57 1.84-6.93 
Menopausal hormone therapy (MHT), n (%)  
  
     
No 2279 (94.3) 177 (6.6)  ref.   
Yes 642 (97.9) 14 (2.1) <0.01 0.32 0.18-0.56 
                  
OR= Odds Ratio, CI= Confidence interval 
a Missing information on soy use, menstruation and/or hormone replacement therapy for 110 participants 
b Chi-squared test 
c Logistic regression mutually adjusted for hormone therapy and menstruation, as well as age. Exclusion of women with regular 
menstruation did not change the estimate for hormone therapy. 







Figure 1 Fractions (%) of different types of dietary supplements among all supplement 





























Figure 2 Mean(SD) age (A), education (B), physical activity (C) and BMI (D) according to 
extent of dietary supplement use (p<0.05 for all four comparisons (ANOVA) unadjusted 
analysis)  




Figure 3 Use of dietary supplements across different categories of medication use, 
deviation (percentage points) from the prevalence among those who do not take any 
medication 
Explanation: Among those who do not take medication, 68% use dietary supplements, assigned 0 
percentage points (black vertical line). Thereby, among women using medication for allergy for instance, 
79% are using dietary supplements. The n column denotes the number of medication users in each 
category. The medication categories are not mutually exclusive as many use more than one medication 
and may contribute to more than one category. 
Abbreviations: COPD=Chronic Obstructive Pulmonary Disease, CVD=Cardiovascular disease, OC=Oral 
Contraceptives 
* “Other” (n=235) includes participants taking medication for gastrointestinal disorders (72%), 
prescription (high dose) vitamins and/or minerals (16%), anemia (6%), glaucoma (3%) dermatological 
disorders (2%), as well as several small user groups (pilocarpine, nicotine, chloroquine, mefloquine, 
dehydroepiandrosterone, and anti-inflammatory eye drops) (7% in all). 
** Except analgesics 
